BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1288 related articles for article (PubMed ID: 22237264)

  • 21. Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma.
    Matsumoto S; Iwakawa R; Kohno T; Suzuki K; Matsuno Y; Yamamoto S; Noguchi M; Shimizu E; Yokota J
    Int J Cancer; 2006 May; 118(10):2498-504. PubMed ID: 16353158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
    Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger KR; Yatabe Y; Beer DG; Powell CA; Riely GJ; Van Schil PE; Garg K; Austin JH; Asamura H; Rusch VW; Hirsch FR; Scagliotti G; Mitsudomi T; Huber RM; Ishikawa Y; Jett J; Sanchez-Cespedes M; Sculier JP; Takahashi T; Tsuboi M; Vansteenkiste J; Wistuba I; Yang PC; Aberle D; Brambilla C; Flieder D; Franklin W; Gazdar A; Gould M; Hasleton P; Henderson D; Johnson B; Johnson D; Kerr K; Kuriyama K; Lee JS; Miller VA; Petersen I; Roggli V; Rosell R; Saijo N; Thunnissen E; Tsao M; Yankelewitz D
    J Thorac Oncol; 2011 Feb; 6(2):244-85. PubMed ID: 21252716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status.
    Sakao Y; Miyamoto H; Oh S; Takahashi N; Inagaki T; Miyasaka Y; Akaboshi T; Sakuraba M
    J Thorac Oncol; 2008 Sep; 3(9):958-62. PubMed ID: 18758296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor receptor mutations in lung adenocarcinoma in Malaysian patients.
    Liam CK; Wahid MI; Rajadurai P; Cheah YK; Ng TS
    J Thorac Oncol; 2013 Jun; 8(6):766-72. PubMed ID: 23575413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
    Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
    Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation.
    Fujita Y; Suda K; Kimura H; Matsumoto K; Arao T; Nagai T; Saijo N; Yatabe Y; Mitsudomi T; Nishio K
    J Thorac Oncol; 2012 Nov; 7(11):1640-4. PubMed ID: 22899358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificities of lung adenocarcinoma in women who have never smoked.
    Mazières J; Rouquette I; Lepage B; Milia J; Brouchet L; Guibert N; Beau-Faller M; Validire P; Hofman P; Fouret P
    J Thorac Oncol; 2013 Jul; 8(7):923-9. PubMed ID: 23608817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
    Chen LF; Chen XY; Yu XB
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
    Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
    J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
    Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
    J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
    Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
    Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung.
    Kobayashi N; Toyooka S; Ichimura K; Soh J; Yamamoto H; Matsuo K; Otani H; Jida M; Kubo T; Tsukuda K; Kiura K; Sano Y; Date H
    J Thorac Oncol; 2008 Jul; 3(7):704-10. PubMed ID: 18594314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type.
    Ninomiya H; Hiramatsu M; Inamura K; Nomura K; Okui M; Miyoshi T; Okumura S; Satoh Y; Nakagawa K; Nishio M; Horai T; Miyata S; Tsuchiya E; Fukayama M; Ishikawa Y
    Lung Cancer; 2009 Feb; 63(2):235-40. PubMed ID: 18571764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological features of lung adenocarcinoma with KRAS mutations.
    Kakegawa S; Shimizu K; Sugano M; Miyamae Y; Kaira K; Araki T; Nakano T; Kamiyoshihara M; Kawashima O; Takeyoshi I
    Cancer; 2011 Sep; 117(18):4257-66. PubMed ID: 21387273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between mutations of epidermal growth factor receptor gene and clinicopathologic features of non-small cell lung cancers].
    Wang F; Fu S; Tang T; Deng L; Zhang X; Li YZ; Shao JY
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):664-6. PubMed ID: 22321543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
    Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
    Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
    Lee HJ; Kim YT; Kang CH; Zhao B; Tan Y; Schwartz LH; Persigehl T; Jeon YK; Chung DH
    Radiology; 2013 Jul; 268(1):254-64. PubMed ID: 23468578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic characteristics of pulmonary adenocarcinomas with and without EGFR mutation.
    Chantranuwat C; Sriuranpong V; Huapai N; Chalermchai T; Leungtaweeboon K; Voravud N; Mutirangura A
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S322-9. PubMed ID: 16623049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.
    Marchetti A; Martella C; Felicioni L; Barassi F; Salvatore S; Chella A; Camplese PP; Iarussi T; Mucilli F; Mezzetti A; Cuccurullo F; Sacco R; Buttitta F
    J Clin Oncol; 2005 Feb; 23(4):857-65. PubMed ID: 15681531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.
    Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M
    J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.